| Literature DB >> 26012568 |
Weiwei Yi1, Xuelian Hu2, Zhiyang Chen3, Leiming Liu4, Yuan Tian2, Hui Chen2, Yu-Sheng Cong1, Fan Yang2, Lianfeng Zhang5, Karl Lenhard Rudolph6, Zhixin Zhang7, Yong Zhao2, Zhenyu Ju1.
Abstract
Wild-type p53-induced phosphatase 1 (Wip1), a phosphatase previously considered as an oncogene, has been implicated in the regulation of thymus homeostasis and neutrophil maturation. However, the role of Wip1 in B-cell development is unknown. We show that Wip1-deficient mice exhibit a significant reduction of B-cell numbers in the bone marrow, peripheral blood, and spleen. A reciprocal transplantation approach revealed a cell-intrinsic defect in early B-cell precursors caused by Wip1 deficiency. Further experiments revealed that Wip1 deficiency led to a sustained activation of p53 in B cells, which led to increased level of apoptosis in the pre-B-cell compartment. Notably, the impairment of B-cell development in Wip1-deficient mice was completely rescued by genetic ablation of p53, but not p21. Therefore, loss of Wip1 phosphatase induces a p53-dependent, but p21-independent, mechanism that impairs B-cell development by enhancing apoptosis in early B-cell precursors. Moreover, Wip1 deficiency exacerbated a decline in B-cell development caused by aging as evidenced in mice with aging and mouse models with serial competitive bone marrow transplantation, respectively. Our present data indicate that Wip1 plays a critical role in maintaining antigen-independent B-cell development in the bone marrow and preventing an aging-related decline in B-cell development.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26012568 PMCID: PMC4520877 DOI: 10.1182/blood-2015-02-624114
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113